Del-Sette Capital Management’s AbbVie ABBV Stock Holding History

Del-Sette Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,534	Closed	-$207K	–	28
2023 Q2	$207K	Sell	1,534 -357	-19%	-$52.4K	0.2%	28
2023 Q1	$301K	Hold	1,891	–	–	0.3%	24
2022 Q4	$306K	Hold	1,891	–	–	0.31%	26
2022 Q3	$254K	Hold	1,891	–	–	0.3%	25
2022 Q2	$290K	Hold	1,891	–	–	0.33%	20
2022 Q1	$307K	Hold	1,891	–	–	0.3%	19
2021 Q4	$256K	Buy	+1,891	New	+$223K	0.25%	31

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Del-Sette Capital Management's ABBV Position: Q3 2023 in Review

Del-Sette Capital Management sold out of AbbVie (ABBV) in Q3 2023, closing a stake of 1,534 shares — an estimated $207K sold.

Del-Sette Capital Management first reported a position in ABBV in Q4 2021 and held it in 7 quarters. The position peaked at $307K in Q1 2022. 3,109 funds tracked by Wall St. Rank hold ABBV as of Q3 2023.

Del-Sette Capital Management reported no remaining AbbVie position as of Q3 2023 after selling out during the quarter.
Del-Sette Capital Management sold 1,534 AbbVie shares in Q3 2023, an estimated $207K.
Del-Sette Capital Management first reported a position in AbbVie in Q4 2021 and held it in 7 quarters.
Del-Sette Capital Management's AbbVie position peaked at $307K in Q1 2022.
3,109 funds tracked by Wall St. Rank held AbbVie as of Q3 2023.

Based on Del-Sette Capital Management's 13F filing for Q3 2023, filed 30 Oct 2023.